237 related articles for article (PubMed ID: 34117312)
1. In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses.
Safini N; Bamouh Z; Hamdi J; Jazouli M; Tadlaoui KO; El Harrak M
Sci Rep; 2021 Jun; 11(1):12395. PubMed ID: 34117312
[TBL] [Abstract][Full Text] [Related]
2. Experimental evaluation of the cross-protection between Sheeppox and bovine Lumpy skin vaccines.
Hamdi J; Bamouh Z; Jazouli M; Boumart Z; Tadlaoui KO; Fihri OF; El Harrak M
Sci Rep; 2020 Jun; 10(1):8888. PubMed ID: 32483247
[TBL] [Abstract][Full Text] [Related]
3. An HRM Assay to Differentiate Sheeppox Virus Vaccine Strains from Sheeppox Virus Field Isolates and other Capripoxvirus Species.
Chibssa TR; Settypalli TBK; Berguido FJ; Grabherr R; Loitsch A; Tuppurainen E; Nwankpa N; Tounkara K; Madani H; Omani A; Diop M; Cattoli G; Diallo A; Lamien CE
Sci Rep; 2019 Apr; 9(1):6646. PubMed ID: 31040355
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of bovine and ovine capripoxviruses (Lumpy skin disease virus and Sheeppox virus) by ivermectin occurs at different stages of propagation in vitro.
Toker EB; Ates O; Yeşilbağ K
Virus Res; 2022 Mar; 310():198671. PubMed ID: 34986368
[TBL] [Abstract][Full Text] [Related]
5. A gel-based PCR method to differentiate sheeppox virus field isolates from vaccine strains.
Chibssa TR; Grabherr R; Loitsch A; Settypalli TBK; Tuppurainen E; Nwankpa N; Tounkara K; Madani H; Omani A; Diop M; Cattoli G; Diallo A; Lamien CE
Virol J; 2018 Apr; 15(1):59. PubMed ID: 29609650
[TBL] [Abstract][Full Text] [Related]
6. Protection of sheep against Rift Valley fever virus and sheep poxvirus with a recombinant capripoxvirus vaccine.
Soi RK; Rurangirwa FR; McGuire TC; Rwambo PM; DeMartini JC; Crawford TB
Clin Vaccine Immunol; 2010 Dec; 17(12):1842-9. PubMed ID: 20876822
[TBL] [Abstract][Full Text] [Related]
7. Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC
Chibssa TR; Kangethe RT; Berguido FJ; Settypalli TBK; Liu Y; Grabherr R; Loitsch A; Sassu EL; Pichler R; Cattoli G; Diallo A; Wijewardana V; Lamien CE
Front Immunol; 2021; 12():666543. PubMed ID: 34211465
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
[TBL] [Abstract][Full Text] [Related]
9. The complete genome sequence of Indian sheeppox vaccine virus and comparative analysis with other capripoxviruses.
Kumar A; Venkatesan G; Hosamani M; Bhanuprakash V; Balamurugan V; Ramakrishnan MA; Singh RK
Gene; 2022 Feb; 810():146085. PubMed ID: 34843879
[TBL] [Abstract][Full Text] [Related]
10. Capripox disease in Ethiopia: Genetic differences between field isolates and vaccine strain, and implications for vaccination failure.
Gelaye E; Belay A; Ayelet G; Jenberie S; Yami M; Loitsch A; Tuppurainen E; Grabherr R; Diallo A; Lamien CE
Antiviral Res; 2015 Jul; 119():28-35. PubMed ID: 25907637
[TBL] [Abstract][Full Text] [Related]
11. Rift Valley Fever Phlebovirus Reassortment Study in Sheep.
Balaraman V; Indran SV; Kim IJ; Trujillo JD; Meekins DA; Shivanna V; Zajac MD; Urbaniak K; Morozov I; Sunwoo SY; Faburay B; Osterrieder K; Gaudreault NN; Wilson WC; Richt JA
Viruses; 2024 May; 16(6):. PubMed ID: 38932172
[TBL] [Abstract][Full Text] [Related]
12. Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep.
Wolff J; Beer M; Hoffmann B
Vaccines (Basel); 2023 Mar; 11(4):. PubMed ID: 37112675
[TBL] [Abstract][Full Text] [Related]
13. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
14. Extended sequencing of vaccine and wild-type capripoxvirus isolates provides insights into genes modulating virulence and host range.
Biswas S; Noyce RS; Babiuk LA; Lung O; Bulach DM; Bowden TR; Boyle DB; Babiuk S; Evans DH
Transbound Emerg Dis; 2020 Jan; 67(1):80-97. PubMed ID: 31379093
[TBL] [Abstract][Full Text] [Related]
15. A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep.
Faburay B; Lebedev M; McVey DS; Wilson W; Morozov I; Young A; Richt JA
Vector Borne Zoonotic Dis; 2014 Oct; 14(10):746-56. PubMed ID: 25325319
[TBL] [Abstract][Full Text] [Related]
16. The genomes of sheeppox and goatpox viruses.
Tulman ER; Afonso CL; Lu Z; Zsak L; Sur JH; Sandybaev NT; Kerembekova UZ; Zaitsev VL; Kutish GF; Rock DL
J Virol; 2002 Jun; 76(12):6054-61. PubMed ID: 12021338
[TBL] [Abstract][Full Text] [Related]
17. Harnessing Attenuation-Related Mutations of Viral Genomes: Development of a Serological Assay to Differentiate between Capripoxvirus-Infected and -Vaccinated Animals.
Berguido FJ; Chibssa TR; Loitsch A; Liu Y; Krstevski K; Djadjovski I; Tuppurainen E; Petrović T; Vidanović D; Caufour P; Settypalli TBK; Grünwald-Gruber C; Grabherr R; Diallo A; Cattoli G; Lamien CE
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140559
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytokines following vaccination of goats with a recombinant capripoxvirus vaccine expressing Rift Valley fever virus proteins.
Ayari-Fakhfakh E; Ghram A; Albina E; Cêtre-Sossah C
Vet Immunol Immunopathol; 2018 Mar; 197():15-20. PubMed ID: 29475501
[TBL] [Abstract][Full Text] [Related]
19.
Rouby SR; Bazid AH; Wasfy M; El-Sayed M
Vet World; 2019 Dec; 12(12):1924-1930. PubMed ID: 32095042
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of live replicating sheeppox vaccine strains in Ovines.
Yogisharadhya R; Bhanuprakash V; Hosamani M; Venkatesan G; Balamurugan V; Bora DP; Bhanot V; Prabhu M; Singh RK
Biologicals; 2011 Nov; 39(6):417-23. PubMed ID: 21993305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
